Company Filing History:
11 out of 388 
1 out of 130 
1 out of 832,880 Years Active: 2001-2021
Title: Innovations of Xiuzhi Susan Sun
Introduction
Xiuzhi Susan Sun is a prominent inventor based in Manhattan, Kansas, known for his significant contributions to the field of peptide-based technologies. With a total of 12 patents to his name, he has made remarkable advancements in the development of hydrogels and vaccine adjuvants.
Latest Patents
One of his latest patents focuses on peptide hydrogel properties and their applications. This invention describes peptide hydrogels that feature a self-assembling, three-dimensional nanofiber matrix. The matrix consists of an amphiphilic peptide and optionally albumin. The peptide includes a terminal hydrophobic region, a central turning region, and a terminal hydrophilic region. The patent also outlines methods for creating these hydrogels and their applications in tissue engineering, hemostatic agents, three-dimensional cell cultures, and drug delivery systems. Another notable patent involves vaccine adjuvants derived from self-assembling peptides. This invention provides pharmaceutical and veterinary compositions, vaccine systems, and methods for enhancing immune responses using peptide-based adjuvants.
Career Highlights
Xiuzhi Susan Sun has worked with the Kansas State University Research Foundation, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding and application of peptide technologies in medical and pharmaceutical fields.
Collaborations
Throughout his career, he has collaborated with notable colleagues, including Greggory S. Karr and Paul A. Seib, who have contributed to his research endeavors.
Conclusion
Xiuzhi Susan Sun's innovative work in peptide hydrogels and vaccine adjuvants showcases his dedication to advancing science and technology. His contributions have the potential to significantly impact medical treatments and drug delivery systems.